C153H184F3N23O2S — CID 158017896
2-[3-(2,5-difluorophenyl)propyl]-4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidine;4-[3-[(2-ethylpiperazin-1-yl)methyl]phenyl]-2-[3-(3-fluorophenyl)propyl]pyrimidine;N-ethyl-N-[[3-[2-(3-pyridin-4-ylpropyl)pyrimidin-4-yl]phenyl]methyl]piperidin-4-amine;4-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]-2-pyridinyl]propyl]phenol;4-[3-[4-[3-[2-[(3R,4R)-3-methylpiperidin-4-yl]ethyl]phenyl]pyrimidin-2-yl]propyl]phenol;1-[[3-[2-(3-thiophen-2-ylpropyl)pyrimidin-4-yl]phenyl]methyl]-1,4-diazepane (PubChem CID 158017896) has the molecular formula C153H184F3N23O2S and a molecular weight of 2466.37 g/mol. Its IUPAC name is 2-[3-(2,5-difluorophenyl)propyl]-4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidine;4-[3-[(2-ethylpiperazin-1-yl)methyl]phenyl]-2-[3-(3-fluorophenyl)propyl]pyrimidine;N-ethyl-N-[[3-[2-(3-pyridin-4-ylpropyl)pyrimidin-4-yl]phenyl]methyl]piperidin-4-amine;4-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]-2-pyridinyl]propyl]phenol;4-[3-[4-[3-[2-[(3R,4R)-3-methylpiperidin-4-yl]ethyl]phenyl]pyrimidin-2-yl]propyl]phenol;1-[[3-[2-(3-thiophen-2-ylpropyl)pyrimidin-4-yl]phenyl]methyl]-1,4-diazepane.
| Compound Name | 2-[3-(2,5-difluorophenyl)propyl]-4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidine;4-[3-[(2-ethylpiperazin-1-yl)methyl]phenyl]-2-[3-(3-fluorophenyl)propyl]pyrimidine;N-ethyl-N-[[3-[2-(3-pyridin-4-ylpropyl)pyrimidin-4-yl]phenyl]methyl]piperidin-4-amine;4-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]-2-pyridinyl]propyl]phenol;4-[3-[4-[3-[2-[(3R,4R)-3-methylpiperidin-4-yl]ethyl]phenyl]pyrimidin-2-yl]propyl]phenol;1-[[3-[2-(3-thiophen-2-ylpropyl)pyrimidin-4-yl]phenyl]methyl]-1,4-diazepane |
|---|---|
| PubChem CID | 158017896 |
| Molecular Formula | C153H184F3N23O2S |
| Molecular Weight | 2466.37 g/mol |
| Exact Mass | 2464.47 |
| IUPAC Name | 2-[3-(2,5-difluorophenyl)propyl]-4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]pyrimidine;4-[3-[(2-ethylpiperazin-1-yl)methyl]phenyl]-2-[3-(3-fluorophenyl)propyl]pyrimidine;N-ethyl-N-[[3-[2-(3-pyridin-4-ylpropyl)pyrimidin-4-yl]phenyl]methyl]piperidin-4-amine;4-[3-[4-[3-[[(2S)-2-methylpiperazin-1-yl]methyl]phenyl]-2-pyridinyl]propyl]phenol;4-[3-[4-[3-[2-[(3R,4R)-3-methylpiperidin-4-yl]ethyl]phenyl]pyrimidin-2-yl]propyl]phenol;1-[[3-[2-(3-thiophen-2-ylpropyl)pyrimidin-4-yl]phenyl]methyl]-1,4-diazepane |
| SMILES | CCC1CNCCN1Cc1cccc(-c2ccnc(CCCc3cccc(F)c3)n2)c1.CCN(Cc1cccc(-c2ccnc(CCCc3ccncc3)n2)c1)C1CCNCC1.C[C@H]1CNCCN1Cc1cccc(-c2ccnc(CCCc3cc(F)ccc3F)n2)c1.C[C@H]1CNCCN1Cc1cccc(-c2ccnc(CCCc3ccc(O)cc3)c2)c1.C[C@H]1CNCC[C@H]1CCc1cccc(-c2ccnc(CCCc3ccc(O)cc3)n2)c1.c1cc(CN2CCCNCC2)cc(-c2ccnc(CCCc3cccs3)n2)c1 |
| InChI | InChI=1S/C27H33N3O.C26H31FN4.C26H33N5.C26H31N3O.C25H28F2N4.C23H28N4S/c1-20-19-28-16-14-23(20)11-8-22-5-2-6-24(18-22)26-15-17-29-27(30-26)7-3-4-21-9-12-25(31)13-10-21;1-2-24-18-28-14-15-31(24)19-21-8-3-9-22(16-21)25-12-13-29-26(30-25)11-5-7-20-6-4-10-23(27)17-20;1-2-31(24-11-16-28-17-12-24)20-22-6-3-7-23(19-22)25-13-18-29-26(30-25)8-4-5-21-9-14-27-15-10-21;1-20-18-27-14-15-29(20)19-22-5-2-6-23(16-22)24-12-13-28-25(17-24)7-3-4-21-8-10-26(30)11-9-21;1-18-16-28-12-13-31(18)17-19-4-2-6-21(14-19)24-10-11-29-25(30-24)7-3-5-20-15-22(26)8-9-23(20)27;1-5-19(18-27-14-4-11-24-13-15-27)17-20(6-1)22-10-12-25-23(26-22)9-2-7-21-8-3-16-28-21/h2,5-6,9-10,12-13,15,17-18,20,23,28,31H,3-4,7-8,11,14,16,19H2,1H3;3-4,6,8-10,12-13,16-17,24,28H,2,5,7,11,14-15,18-19H2,1H3;3,6-7,9-10,13-15,18-19,24,28H,2,4-5,8,11-12,16-17,20H2,1H3;2,5-6,8-13,16-17,20,27,30H,3-4,7,14-15,18-19H2,1H3;2,4,6,8-11,14-15,18,28H,3,5,7,12-13,16-17H2,1H3;1,3,5-6,8,10,12,16-17,24H,2,4,7,9,11,13-15,18H2/t20-,23+;;;20-;18-;/m0..00./s1 |
| InChIKey | FFRSIJJTQZJLDD-BFZSBCGSSA-N |
| XLogP | 27.12 |
| TPSA | 283.52 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 26 |
| Rotatable Bonds | 46 |
| Heavy Atoms | 182 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2466.37 |
| LogP ≤ 5 | 27.12 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 26 |